Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

View 0 Studies Requested

Trial Summary

About CDAS Project, PI, Publications: Validation of findings from the Epigenome-Wide Association Study of Breast Cancer

Datasets


Site: Breast

Inclusion Criteria:

  • Intervention Arm Females
  • No Rare Cancers
  • No Prior History of Any Cancer
  • T0 DNA Extracted from 2009-00553 or T0 Source Available
  • Pre-Exit T0 DNA Extracted from 2009-00553 or T0 Source Available
  • T0 Material is 4-7 Years Pre-Dx (Cases)
  • Source Material Available in T3/T4/T5
  • Pre-Exit Source Material Available in T3/T4/T5
  • T3-T5 Material is 1-3 Years Pre-Dx (Cases)

Matching Factors:

  • Age at Randomization (5 year intervals)
  • Study Year of Blood Draw
  • Calendar Year of Blood Draw
  • Material Type

Match Ratio: 1:1

Match Technique: Frequency matching only non-cases as controls.

Additional Matching Comments: Matching factors pertaining to blood draw apply to both time points.


Analytes:

  • C6orf79 percent methylated
  • ERCC1 percent methylated
  • MGAT4C percent methylated
  • OPTN percent methylated
  • PRKCDBP percent methylated
  • methylated C6orf79
  • methylated ERCC1
  • methylated MGAT4C
  • methylated OPTN
  • methylated PRKCDBP
  • unmethylated C6orf79
  • unmethylated ERCC1
  • unmethylated MGAT4C
  • unmethylated OPTN
  • unmethylated PRKCDBP

Number of Cases: 300

Number of Controls: 300